2023 - Press Releases

Global sites

This website is intended for people seeking information on AstraZeneca's worldwide business. We also have country sites; click the 'Global sites' link for the directory.

Veeva ID: CA-6862
Date of next review: August 2022

Quick Links

CASL
Accessibility
Social Media Community Guidelines
Modern Slavery Statement

Resources

Site Map

Social Media

Twitter

utility links

Contact Us
Legal Notice
Privacy Policy
Cookie policy

You are now leaving AstraZeneca.ca

You have selected a link that will take you to an external site.

AstraZeneca.ca provides this link as a service to website visitors. AstraZeneca.ca is not responsible for the contents, capabilities or privacy policy of any external websites.

We encourage you to read the privacy policy of every wesbite you visit.

Click 'cancel' to return to AstraZeneca's site or 'continue' to proceed.

Cancel Continue

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree